157 related articles for article (PubMed ID: 12083953)
1. Genetics of multiple sclerosis: linkage and association studies.
Giordano M; D'Alfonso S; Momigliano-Richiardi P
Am J Pharmacogenomics; 2002; 2(1):37-58. PubMed ID: 12083953
[TBL] [Abstract][Full Text] [Related]
2. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
[TBL] [Abstract][Full Text] [Related]
3. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia.
Marrosu MG; Murru R; Murru MR; Costa G; Zavattari P; Whalen M; Cocco E; Mancosu C; Schirru L; Solla E; Fadda E; Melis C; Porru I; Rolesu M; Cucca F
Hum Mol Genet; 2001 Dec; 10(25):2907-16. PubMed ID: 11741834
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
[TBL] [Abstract][Full Text] [Related]
5. The genetics of multiple sclerosis. A review.
Kalman B; Lublin FD
Biomed Pharmacother; 1999 Sep; 53(8):358-70. PubMed ID: 10554670
[TBL] [Abstract][Full Text] [Related]
6. Reappraisal of HLA in multiple sclerosis: close linkage in multiplex families.
Tienari PJ; Wikström J; Koskimies S; Partanen J; Palo J; Peltonen L
Eur J Hum Genet; 1993; 1(4):257-68. PubMed ID: 8081940
[TBL] [Abstract][Full Text] [Related]
7. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
8. Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics Group.
Reboul J; Mertens C; Levillayer F; Eichenbaum-Voline S; Vilkoren T; Cournu I; Babron MC; Lyon-Caen O; Clerget-Darpoux F; Edan G; Clanet M; Brahic M; Bureau JF; Fontaine B; Liblau R
J Neuroimmunol; 2000 Jan; 102(1):107-12. PubMed ID: 10626674
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis.
Compston A; Kellar-Wood H; Wood N
Baillieres Clin Neurol; 1994 Aug; 3(2):353-71. PubMed ID: 7952852
[TBL] [Abstract][Full Text] [Related]
10. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.
Quelvennec E; Bera O; Cabre P; Alizadeh M; Smadja D; Jugde F; Edan G; Semana G
Tissue Antigens; 2003 Feb; 61(2):166-71. PubMed ID: 12694585
[TBL] [Abstract][Full Text] [Related]
11. The current state of multiple sclerosis genetic research.
Rubio JP; Speed TP; Bahlo M; Kilpatrick TJ; Foote SJ
Ann Acad Med Singap; 2000 May; 29(3):322-30. PubMed ID: 10976385
[TBL] [Abstract][Full Text] [Related]
12. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
[TBL] [Abstract][Full Text] [Related]
13. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews.
Kwon OJ; Karni A; Israel S; Brautbar C; Amar A; Meiner Z; Abramsky O; Karussis D
Arch Neurol; 1999 May; 56(5):555-60. PubMed ID: 10328250
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland.
Haegert DG; Swift FV; Benedikz J
Neurology; 1996 Apr; 46(4):1107-11. PubMed ID: 8780100
[TBL] [Abstract][Full Text] [Related]
15. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
[TBL] [Abstract][Full Text] [Related]
16. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.
Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ
Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150
[TBL] [Abstract][Full Text] [Related]
17. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group.
Haines JL; Terwedow HA; Burgess K; Pericak-Vance MA; Rimmler JB; Martin ER; Oksenberg JR; Lincoln R; Zhang DY; Banatao DR; Gatto N; Goodkin DE; Hauser SL
Hum Mol Genet; 1998 Aug; 7(8):1229-34. PubMed ID: 9668163
[TBL] [Abstract][Full Text] [Related]
18. Genetics in multiple sclerosis: past and future perspectives.
Harbo HF; Spurkland A
Acta Neurol Scand Suppl; 2007; 187():34-8. PubMed ID: 17419826
[TBL] [Abstract][Full Text] [Related]
19. Linkage analysis conditional on HLA status in a large North American pedigree supports the presence of a multiple sclerosis susceptibility locus on chromosome 12p12.
Vitale E; Cook S; Sun R; Specchia C; Subramanian K; Rocchi M; Nathanson D; Schwalb M; Devoto M; Rohowsky-Kochan C
Hum Mol Genet; 2002 Feb; 11(3):295-300. PubMed ID: 11823448
[TBL] [Abstract][Full Text] [Related]
20. Genetic susceptibility to multiple sclerosis.
Haegert DG; Marrosu MG
Ann Neurol; 1994 Dec; 36 Suppl 2():S204-10. PubMed ID: 7998789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
